150 related articles for article (PubMed ID: 9729586)
21. Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock.
Araújo CV; Barbosa-Filho JM; Cordeiro RS; Tibiriçá E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):267-75. PubMed ID: 11284440
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites.
Burhop KE; van der Zee H; Bizios R; Kaplan JE; Malik AB
Am Rev Respir Dis; 1986 Sep; 134(3):548-54. PubMed ID: 3752711
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
Chen CR; Voelkel NF; Chang SW
J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
[TBL] [Abstract][Full Text] [Related]
24. Sustained effects of platelet-activating factor infusion in piglets.
Stambouly JJ; Bradley LM; Czaja JF; Goldstein RE
Pediatr Res; 1991 Sep; 30(3):261-5. PubMed ID: 1945566
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor. A possible role in the modulation of the vasomotor tone and blood pressure.
Lopes-Martins RA; Araújo CV; Estato V; Moreira S; Cordeiro RS; Tibiriçá EV
Adv Exp Med Biol; 1996; 416():223-30. PubMed ID: 9131152
[No Abstract] [Full Text] [Related]
26. Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney.
Perico N; Lapinski R; Konopka K; Aiello S; Noris M; Remuzzi G
J Am Soc Nephrol; 1997 Sep; 8(9):1391-8. PubMed ID: 9294830
[TBL] [Abstract][Full Text] [Related]
27. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3.
Hostettler ME; Knapp PE; Carlson SL
Glia; 2002 May; 38(3):228-39. PubMed ID: 11968060
[TBL] [Abstract][Full Text] [Related]
28. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.
Siebeck M; Weipert J; Keser C; Kohl J; Spannagl M; Machleidt W; Schweiberer L
J Trauma; 1991 Jul; 31(7):942-9; discussion 949-50. PubMed ID: 1906548
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
31. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
[TBL] [Abstract][Full Text] [Related]
32. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
Christman BW; Lefferts PL; Blair IA; Snapper JR
Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
[TBL] [Abstract][Full Text] [Related]
33. EDRF inhibition attenuates the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs.
Moore P; Velvis H; Fineman JR; Soifer SJ; Heymann MA
J Appl Physiol (1985); 1992 Nov; 73(5):2151-7. PubMed ID: 1474097
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro.
Borman RA; Jewell R; Hillier K
Br J Pharmacol; 1998 Jan; 123(2):231-6. PubMed ID: 9489610
[TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor increases lung vascular permeability to protein.
Burhop KE; Garcia JG; Selig WM; Lo SK; van der Zee H; Kaplan JE; Malik AB
J Appl Physiol (1985); 1986 Dec; 61(6):2210-7. PubMed ID: 3804927
[TBL] [Abstract][Full Text] [Related]
36. The developmental effects of prostaglandin D2 on the pulmonary and systemic circulations in the newborn lamb.
Soifer SJ; Morin FC; Kaslow DC; Heymann MA
J Dev Physiol; 1983 Aug; 5(4):237-50. PubMed ID: 6579103
[TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons.
DeCoster MA; Mukherjee PK; Davis RJ; Bazan NG
J Neurosci Res; 1998 Aug; 53(3):297-303. PubMed ID: 9698157
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist.
Kruse-Elliott KT; Albert DH; Summers JB; Carter GW; Zimmerman JJ; Grossman JE
Shock; 1996 Apr; 5(4):265-73. PubMed ID: 8721386
[TBL] [Abstract][Full Text] [Related]
39. BB-882 is a potent antagonist of the haemodynamic changes induced by platelet-activating factor in pigs.
Abu-Zidan FM; Walther S; Lennquist S
Pharmacol Toxicol; 1996 Jan; 78(1):23-7. PubMed ID: 8685082
[TBL] [Abstract][Full Text] [Related]
40. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
